WASHINGTON, January 2, 2003 (LifeSiteNews.com) - The U.S. Food and Drug Administration (FDA) has launched an investigation into much-publicized claims by the American-based Raelian research company Clonaid (see previous item) that it has created the first-ever cloned human baby. The FDA - whose mandate includes regulating human trials on U.S. soil—says it is looking into the allegations even though the company claims the cloning was done outside the country. Brigitte Boisselier, chief executive of Clonaid, told reporters late last week that, following the birth by Caesarian section of a little girl named “Eve,” four other women are due to give birth to clones in the next few weeks: one somewhere in Europe, another in North America and two in Asia. Prosecutors in Korea are now investigating claims from Clonaid officials in Seoul that the company impregnated a South Korean woman with a cloned human embryo and that she left the country in July. For BBC News coverage see: http://news.bbc.co.uk/2/hi/health/2613733.stm For a report on the investigation in Korea see: http://ca.news.yahoo.com/021231/6/r4fp.html